Hyam Levitsky - 12 Apr 2023 Form 4 Insider Report for Century Therapeutics, Inc. (IPSC)

Role
President of R&D
Signature
/s/ Michael Diem, Attorney-in-Fact
Issuer symbol
IPSC
Transactions as of
12 Apr 2023
Net transactions value
$0
Form type
4
Filing time
14 Apr 2023, 19:56:44 UTC
Previous filing
04 Apr 2023
Next filing
11 Mar 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IPSC Stock Option (right to buy) Award $0 +131,250 $0.000000 131,250 12 Apr 2023 Common Stock 131,250 $2.91 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests 25% on April 12, 2024, with the remaining 75% vesting in 36 equal monthly installments, subject to the Reporting Person's continued service with the Issuer.